Syringes for Pfizer’s epoetin biosimilar have been outfitted with Needle-Trap needle protection labels from Schreiner MediPharm. The pairing marks the first time Needle-Trap will be utilized with medication for the treatment of anemia. The newly equipped needles will begin usage in Germany and Austria, followed by a rollout on the broader European market.
Pfizer has been using MediPharm's Needle-Trap on millions of syringes for a heparin drug since 2009.
Needle-Trap features a unique design: The plastic needle trap is an integral component of the label for prefilled syringes, and serves to secure the needle after the injection has been performed.
Schreiner MediPharm’s Needle-Trap meets the requirements of EU Directive 2010/32/EU, U.S. NIOSH for safe instruments and DIN EN ISO 23908 for sharps injury protection. In addition, it has been cleared by an FDA 510(k) Premarket Notification in the United States.